CGTX insider buying

Every open-market purchase of Cognition Therapeutics Inc (CGTX) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$32.49K

Insiders buying (12m)3

Purchases on record3

Last purchase filedApr 20, 2026

In the last 12 months, 3 insiders of Cognition Therapeutics Inc bought $32.49K of CGTX stock on the open market in 3 reported purchases. The most recent was filed on Apr 20, 2026: Doyle John Brendan (Chief Financial Officer) bought 10,000 shares at $1.13, worth $11.30K.

Get the next CGTX insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All CGTX insider purchases

Filed	Insider	Value	Shares	Price	Stake	Trade
Apr 20	Doyle John BrendanChief Financial Officer	$11.30K	10,000	$1.13	+2%	Apr 16	SEC
Apr 20	Ricciardi LisaCEO & President, Director	$10.09K	9,175	$1.10	+0%	Apr 16	SEC
Apr 20	Caggiano AnthonyChief Medical Officer	$11.10K	10,000	$1.11	+1%	Apr 16	SEC